337 related articles for article (PubMed ID: 34769149)
1. Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer.
Wulf AM; Moreno MM; Paka C; Rampasekova A; Liu KJ
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769149
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic lymphoma kinase (alk), a neuroblastoma associated gene, is expressed in neural crest domains during embryonic development of Xenopus.
Moreno MM; Barrell WB; Godwin A; Guille M; Liu KJ
Gene Expr Patterns; 2021 Jun; 40():119183. PubMed ID: 34020009
[TBL] [Abstract][Full Text] [Related]
3. The ALK receptor in sympathetic neuron development and neuroblastoma.
Janoueix-Lerosey I; Lopez-Delisle L; Delattre O; Rohrer H
Cell Tissue Res; 2018 May; 372(2):325-337. PubMed ID: 29374774
[TBL] [Abstract][Full Text] [Related]
4. Targeting anaplastic lymphoma kinase in neuroblastoma.
Umapathy G; Mendoza-Garcia P; Hallberg B; Palmer RH
APMIS; 2019 May; 127(5):288-302. PubMed ID: 30803032
[TBL] [Abstract][Full Text] [Related]
5. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells.
Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A
Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425
[TBL] [Abstract][Full Text] [Related]
6. Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.
Montavon G; Jauquier N; Coulon A; Peuchmaur M; Flahaut M; Bourloud KB; Yan P; Delattre O; Sommer L; Joseph JM; Janoueix-Lerosey I; Gross N; Mühlethaler-Mottet A
Oncotarget; 2014 Jun; 5(12):4452-66. PubMed ID: 24947326
[TBL] [Abstract][Full Text] [Related]
7. Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.
Cazes A; Lopez-Delisle L; Tsarovina K; Pierre-Eugène C; De Preter K; Peuchmaur M; Nicolas A; Provost C; Louis-Brennetot C; Daveau R; Kumps C; Cascone I; Schleiermacher G; Prignon A; Speleman F; Rohrer H; Delattre O; Janoueix-Lerosey I
Oncotarget; 2014 May; 5(9):2688-702. PubMed ID: 24811913
[TBL] [Abstract][Full Text] [Related]
8. The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.
Mus LM; Lambertz I; Claeys S; Kumps C; Van Loocke W; Van Neste C; Umapathy G; Vaapil M; Bartenhagen C; Laureys G; De Wever O; Bexell D; Fischer M; Hallberg B; Schulte J; De Wilde B; Durinck K; Denecker G; De Preter K; Speleman F
Sci Rep; 2020 Jan; 10(1):218. PubMed ID: 31937834
[TBL] [Abstract][Full Text] [Related]
9. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
10. ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells.
Gonzalez Malagon SG; Liu KJ
J Exp Neurosci; 2018; 12():1179069518792499. PubMed ID: 30127638
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
12. Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides.
Ota Y; Yoda H; Inoue T; Watanabe T; Shinozaki Y; Takatori A; Nagase H
PLoS One; 2021; 16(9):e0257718. PubMed ID: 34591871
[TBL] [Abstract][Full Text] [Related]
13. WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma.
Becker J; Wilting J
Cell Mol Life Sci; 2018 Mar; 75(6):1057-1070. PubMed ID: 29058015
[TBL] [Abstract][Full Text] [Related]
14. Linking neural crest development to neuroblastoma pathology.
Gonzalez Malagon SG; Liu KJ
Development; 2022 Aug; 149(15):. PubMed ID: 35905010
[TBL] [Abstract][Full Text] [Related]
15. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
[TBL] [Abstract][Full Text] [Related]
16. Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.
Sattu K; Hochgräfe F; Wu J; Umapathy G; Schönherr C; Ruuth K; Chand D; Witek B; Fuchs J; Li PK; Hugosson F; Daly RJ; Palmer RH; Hallberg B
FEBS J; 2013 Nov; 280(21):5269-82. PubMed ID: 23889739
[TBL] [Abstract][Full Text] [Related]
17. Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways.
Van den Eynden J; Umapathy G; Ashouri A; Cervantes-Madrid D; Szydzik J; Ruuth K; Koster J; Larsson E; Guan J; Palmer RH; Hallberg B
Sci Signal; 2018 Nov; 11(557):. PubMed ID: 30459281
[TBL] [Abstract][Full Text] [Related]
18. Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma.
Chand D; Yamazaki Y; Ruuth K; Schönherr C; Martinsson T; Kogner P; Attiyeh EF; Maris J; Morozova O; Marra MA; Ohira M; Nakagawara A; Sandström PE; Palmer RH; Hallberg B
Dis Model Mech; 2013 Mar; 6(2):373-82. PubMed ID: 23104988
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus.
Gonzalez Malagon SG; Lopez Muñoz AM; Doro D; Bolger TG; Poon E; Tucker ER; Adel Al-Lami H; Krause M; Phiel CJ; Chesler L; Liu KJ
Nat Commun; 2018 Mar; 9(1):1126. PubMed ID: 29555900
[TBL] [Abstract][Full Text] [Related]
20. Tumour-derived substrate-adherent cells promote neuroblastoma survival through secreted trophic factors.
Li J; Wang Y; Li L; Or PM; Wai Wong C; Liu T; Ho WLH; Chan AM
Mol Oncol; 2021 Aug; 15(8):2011-2025. PubMed ID: 33932101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]